{"created":"2023-05-15T09:05:48.690756+00:00","id":7181,"links":{},"metadata":{"_buckets":{"deposit":"3c51fb89-5b9e-4c2c-8d8d-f86e853f64c3"},"_deposit":{"created_by":11,"id":"7181","owners":[11],"pid":{"revision_id":0,"type":"depid","value":"7181"},"status":"published"},"_oai":{"id":"oai:hirosaki.repo.nii.ac.jp:00007181","sets":["557:561:1115"]},"author_link":["13005","22494","11745","11302","22493","14410","21258","8087","21104","22492","13337","12410","11741","14721"],"item_3_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2023-03-22","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1-4","bibliographicPageEnd":"66","bibliographicPageStart":"54","bibliographicVolumeNumber":"73","bibliographic_titles":[{"bibliographic_title":"弘前医学"},{"bibliographic_title":"Hirosaki Medical Journal","bibliographic_titleLang":"en"}]}]},"item_3_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Background: Positron emission tomography（PET） is the standard method for metabolic and quantitative evaluation of therapeutic response to chemotherapy in solid tumors. This study determined the ability of PET parameters used in combination in predicting recurrence-free survival（RFS）after neoadjuvant chemotherapy （NAC）and operation for esophageal cancer.\nMethods: This single-center retrospective study included 96 patients who underwent 18F-fluorodeoxyglucose-PET/computed tomography before and after NAC. Maximum standardised uptake value（SUVmax）after NAC and the rate of change in SUVmax following NAC（ΔSUVmax）were determined to examine their relationship with postoperative recurrence and clinicopathological factors.\nResults: Receiver operating characteristic curves, with recurrence after NAC as the event, were used to determine optimal cut-off SUVmax and ΔSUVmax of 6.8 and 45.7, respectively. Using these cut-off values, the patients were classified into four groups: Group A, SUVmax > 6.8 and ΔSUVmax ≤ 45.7; Group B, SUVmax > 6.8 and ΔSUVmax > 45.7; Group C, SUVmax ≤ 6.8 and ΔSUVmax ≤ 45.7; and Group D, SUVmax ≤ 6.8 and ΔSUVmax > 45.7. Of the four groups, Group D had the longest RFS compared to the other groups.\nConclusion: Combination of SUVmax with ΔSUVmax was useful for evaluating the effects of NAC in patients with esophageal cancer.","subitem_description_type":"Abstract"}]},"item_3_publisher_35":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"弘前大学大学院医学研究科"}]},"item_3_radio_42":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_radio_item":"Article"}]},"item_3_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00211444","subitem_source_identifier_type":"NCID"}]},"item_3_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0439-1721","subitem_source_identifier_type":"ISSN"}]},"item_3_text_4":{"attribute_name":"著者所属","attribute_value_mlt":[{"subitem_text_value":"Department of Medical Oncology, Hirosaki University Graduate School of Medicine"},{"subitem_text_value":"Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine"},{"subitem_text_value":"Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine"},{"subitem_text_value":"Department of Radiology, Aomori National Hospital"},{"subitem_text_value":"Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine"},{"subitem_text_value":"Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine"},{"subitem_text_value":"Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine"},{"subitem_text_value":"Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine"},{"subitem_text_value":"Department of Radiology, Hirosaki University Graduate School of Medicine"},{"subitem_text_value":"Department of Medical Oncology, Hirosaki University Graduate School of Medicine"},{"subitem_text_value":"Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine"},{"subitem_text_value":"Department of Radiology, Hirosaki University Graduate School of Medicine"},{"subitem_text_value":"Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine"},{"subitem_text_value":"Department of Medical Oncology, Hirosaki University Graduate School of Medicine"}]},"item_3_version_type_18":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Saito, Kensuke"}],"nameIdentifiers":[{"nameIdentifier":"22492","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Yoshizawa, Tadashi"}],"nameIdentifiers":[{"nameIdentifier":"14410","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Morohashi, Satoko"}],"nameIdentifiers":[{"nameIdentifier":"13337","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Seino, Hiroko"}],"nameIdentifiers":[{"nameIdentifier":"11741","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Goto, Shintaro"}],"nameIdentifiers":[{"nameIdentifier":"21258","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Muroya, Takahiro"}],"nameIdentifiers":[{"nameIdentifier":"13005","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Yokoyama, Hiroshi"}],"nameIdentifiers":[{"nameIdentifier":"8087","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Yoshida, Eri"}],"nameIdentifiers":[{"nameIdentifier":"14721","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Miura, Hiroyuki"}],"nameIdentifiers":[{"nameIdentifier":"11745","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Yu, Chen"}],"nameIdentifiers":[{"nameIdentifier":"22493","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Kijima, Hiroshi"}],"nameIdentifiers":[{"nameIdentifier":"12410","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"208","nameIdentifierScheme":"研究者総覧","nameIdentifierURI":"http://hue2.jm.hirosaki-u.ac.jp/html/208_ja.html"}]},{"creatorNames":[{"creatorName":"Kakeda, Shingo"}],"nameIdentifiers":[{"nameIdentifier":"22494","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Hakamada, Kenichi"}],"nameIdentifiers":[{"nameIdentifier":"11302","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"257","nameIdentifierScheme":"研究者総覧","nameIdentifierURI":"http://hue2.jm.hirosaki-u.ac.jp/html/257_ja.html"}]},{"creatorNames":[{"creatorName":"Sato, Atsushi"}],"nameIdentifiers":[{"nameIdentifier":"21104","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2023-04-24"}],"displaytype":"detail","filename":"Hirosaki Med J 73-1-4_54.pdf","filesize":[{"value":"1.6 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"Hirosaki Med J 73-1-4_54","url":"https://hirosaki.repo.nii.ac.jp/record/7181/files/Hirosaki Med J 73-1-4_54.pdf"},"version_id":"eb25e3c5-aa6a-4e3f-9c8a-05f94b4fb411"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"esophageal cancer","subitem_subject_scheme":"Other"},{"subitem_subject":"fluorodeoxyglucose positron emission tomography","subitem_subject_scheme":"Other"},{"subitem_subject":"standardised uptake value","subitem_subject_scheme":"Other"},{"subitem_subject":"prognostic factor","subitem_subject_scheme":"Other"},{"subitem_subject":"neoadjuvant therapy","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Combined utility of maximum standardized uptake value and its change after neoadjuvant chemotherapy in predicting postoperative recurrence in esophageal cancer","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Combined utility of maximum standardized uptake value and its change after neoadjuvant chemotherapy in predicting postoperative recurrence in esophageal cancer"}]},"item_type_id":"3","owner":"11","path":["1115"],"pubdate":{"attribute_name":"公開日","attribute_value":"2023-04-24"},"publish_date":"2023-04-24","publish_status":"0","recid":"7181","relation_version_is_last":true,"title":["Combined utility of maximum standardized uptake value and its change after neoadjuvant chemotherapy in predicting postoperative recurrence in esophageal cancer"],"weko_creator_id":"11","weko_shared_id":-1},"updated":"2023-05-15T09:27:59.808547+00:00"}